No Data
No Data
First Pharmaceutical (600833.SH) announced first-quarter results, net profit of 36.5538 million yuan, a year-on-year increase of 21.75%
First Pharmaceutical (600833.SH) disclosed its report for the first quarter of 2024. The company achieved operating income during the reporting period...
Weak Statutory Earnings May Not Tell The Whole Story For Shanghai No.1 PharmacyLtd (SHSE:600833)
A lackluster earnings announcement from Shanghai No.1 Pharmacy Co.,Ltd. (SHSE:600833) last week didn't sink the stock price. Our analysis suggests that along with soft profit numbers, investors shoul
First Pharmaceutical (600833.SH): Net profit in 2023 fell 37.81% year-on-year, and plans to distribute 1.25 yuan to 10 shares
On March 29, Ge Longhui (600833.SH) released its 2023 annual report. Operating revenue was 1.8 billion yuan, down 31.49% year on year, net profit was 89.275 million yuan, down 37.81% year on year, after deducting non-net profit of 10.875,800 yuan, down 92.23% year on year, with basic earnings of 0.40 yuan per share. A cash dividend of 1.25 yuan is distributed to all shareholders of the company for every 10 shares.
Shanghai No.1 Pharmacy's Chairman, Vice Chairman Step Down; New Chairman Named
Shanghai No.1 Pharmacy (SHA:600833) Chairman Sun Wei and Vice Chairman Zhou Yu resigned from their roles, according to filings on Thursday. The Chinese pharmaceutical wholesaling and retailing company
First Pharmaceutical (600833.SH): Chairman Sun Wei resigns
Gelonghui, Feb. 7 | First Pharmaceutical (600833.SH) announced that the board of directors received a written application for resignation from Mr. Sun Wei, the chairman of the company. According to the part-time regulations for state-owned enterprise leaders, Mr. Sun Wei applied to resign as chairman of the 10th board of directors of the company, member of the nomination committee, member of the remuneration and assessment committee, etc., and confirmed to the board of directors that there were no differences of opinion with the board of directors, nor any other matters requiring shareholders to be notified due to his resignation.
Why Investors Shouldn't Be Surprised By Shanghai No.1 Pharmacy Co.,Ltd.'s (SHSE:600833) Low P/E
Shanghai No.1 Pharmacy Co.,Ltd.'s (SHSE:600833) price-to-earnings (or "P/E") ratio of 17.2x might make it look like a buy right now compared to the market in China, where around half of the companies
No Data